Date: May 11, 2010 Source: (
click here to go to the source)
InDevR, developer of advanced life
science product
s, announced
its
collaboration with
scientists in
the
Influenza Division of the Centers for Disease Control and Prevention (CDC)
in Atlanta
to develop
a
unique influenza microarray
assay
.
InDevR and
CDC
scientists
are
working to
develop
a low density
microarray capable of
screening
influenza A viruses for gene
tic
reassortment.
The microarray will be coupled with InDevR's inexpensive,
compact ampliPHOX™ colorimetric detection system.
This
simple yet
powerful
microarray
assay
has the
potential to enhance
influenza
surveillance
efforts around the globe by providing a
n
affordable
tool
for
public health scientists that do not have access to
full genome sequencin
g.
Enabling point of service
screening will help to more efficiently
track the emergence of viruses like the swine origin H1N1, where
genetic mixing occurred between influenza viruses adapted to different species.
F
unded by an internal
CDC grant, the
microarray
will be developed over the next two years.
"We are excited
about this collaboration with CDC that will
leverage our combined experience with low
-
density microarray development, CDC's expertise in influenza surveillance,
and InDevR's unique new
ampliPHOX colorimetric detection technology. This
compelling
combinati
on of technologies could
greatly enhance global influenza surveillance efforts
, which in turn, will provide essential and time
-
critical info
rmation for vaccine preparation
,"
said
Dr. Kathy Rowlen, InDevR's co
-
founder and CEO.
